BioSpace News Archive

Azurity Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of FLEQSUVY ™ (baclofen oral suspension), 25 mg per 5 mL (5 mg/mL), Concentrated Formulation for the treatment of spasticity from multiple sclerosis (MS) or patients with spinal cord injuries and other spinal cord diseases.

Castle Biosciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference.

NeoImmuneTech, Inc. today announced that the first patient has been dosed in the Phase 2a portion of a study evaluating NT-I7 (efineptakin alfa).

Bruker Corporation (Nasdaq: BRKR) today announced the launch of its timsTOF MALDI PharmaPulse® (timsTOF MPP) system, a groundbreaking new high-end solution for unbiased, deep HTS and uHTS based on label-free mass spectrometry.

Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform.

ViiV Healthcare today announced the presentation of company and investigator sponsored abstracts from its industry-leading HIV treatment and prevention portfolio of approved long-acting medicines and 2-drug regimens.

Aurora Spine Corporation announced today that it has received “Notice of Allowance” for its patent from the United States Patent and Trademark Office (USPTO), for the invention: ‘Spinal Implant for Motion Preservation or Fusion’.

EnCapsid Therapeutics Inc., the pioneer in synthetic virology, has obtained results to show that its modular and versatile capsid modification technology can be used to engineer AAV vectors with enhanced therapeutic properties.

Achilles Therapeutics plc today announced the appointment of Alena Gros, Ph.D. and Ben Creelan, M.D. to its Scientific Advisory Board (SAB).

Titan Medical Inc. today announced that it has surpassed 200 patents and patent applications.